Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-15

Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lifitegrast for dry eye disease has completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifitegrast (lifitegrast)

Snippet

Sponsor: Shire | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-03-15